These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7811999)
1. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Paterson RL; Kelleher C; Amankonah TD; Streib JE; Xu JW; Jones JF; Gelfand EW Blood; 1995 Jan; 85(2):456-64. PubMed ID: 7811999 [TBL] [Abstract][Full Text] [Related]
2. Activation of human thymocytes after infection by EBV. Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809 [TBL] [Abstract][Full Text] [Related]
3. EBV infection of T cells: potential role in malignant transformation. Kelleher CA; Dreyfus DH; Jones JF; Gelfand EW Semin Cancer Biol; 1996 Aug; 7(4):197-207. PubMed ID: 8946604 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Kelleher CA; Paterson RK; Dreyfus DH; Streib JE; Xu JW; Takase K; Jones JF; Gelfand EW Virology; 1995 Apr; 208(2):685-95. PubMed ID: 7747440 [TBL] [Abstract][Full Text] [Related]
5. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines. Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201 [TBL] [Abstract][Full Text] [Related]
6. Infection of human thymocytes by Epstein-Barr virus. Watry D; Hedrick JA; Siervo S; Rhodes G; Lamberti JJ; Lambris JD; Tsoukas CD J Exp Med; 1991 Apr; 173(4):971-80. PubMed ID: 1706754 [TBL] [Abstract][Full Text] [Related]
7. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells. Smith NA; Coleman CB; Gewurz BE; Rochford R J Virol; 2020 May; 94(11):. PubMed ID: 32238579 [TBL] [Abstract][Full Text] [Related]
8. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687 [TBL] [Abstract][Full Text] [Related]
9. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Peng M; Lundgren E Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369 [TBL] [Abstract][Full Text] [Related]
10. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. Hosoi H; Imadome KI; Tamura S; Kuriyama K; Murata S; Yamashita Y; Mushino T; Oiwa T; Kobata H; Nishikawa A; Nakakuma H; Hanaoka N; Isobe Y; Ohshima K; Sonoki T Leuk Res; 2017 Apr; 55():1-5. PubMed ID: 28110206 [TBL] [Abstract][Full Text] [Related]
11. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420 [TBL] [Abstract][Full Text] [Related]
12. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588 [TBL] [Abstract][Full Text] [Related]
13. Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2. Romano G; Guan M; Long WK; Henderson EE Virology; 1997 Oct; 237(1):23-32. PubMed ID: 9344904 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV. Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731 [TBL] [Abstract][Full Text] [Related]
15. Patterned entry and egress by Epstein-Barr virus in polarized CR2-positive epithelial cells. Chodosh J; Gan Yj; Holder VP; Sixbey JW Virology; 2000 Jan; 266(2):387-96. PubMed ID: 10639323 [TBL] [Abstract][Full Text] [Related]
16. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. Shannon-Lowe C; Adland E; Bell AI; Delecluse HJ; Rickinson AB; Rowe M J Virol; 2009 Aug; 83(15):7749-60. PubMed ID: 19439479 [TBL] [Abstract][Full Text] [Related]
17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH; Wolf H; Minarovits J Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410 [TBL] [Abstract][Full Text] [Related]
18. EBV binds to lymphocytes of transgenic mice that express the human CR2 gene. Kearns-Jonker M; Monell-Torrens E; Abbasi F; Holers VM; Notkins AL; Sigounas G Virus Res; 1997 Jul; 50(1):85-94. PubMed ID: 9255938 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript. Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules. Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]